Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yumi Kambayashi

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
Oncoimmunology|December 18, 2012
Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growthTaku Fujimura, Yumi Kambayashi, Setsuya Aiba
Acta Dermato-Venereologica|April 11, 2013
Comparison of immunosuppressive and immunomodulatory cells in keratoacanthoma and cutaneous squamous cell carcinomaYumi Kambayashi, Taku Fujimura, Setsuya Aiba
Case Reports in Dermatology|April 30, 2013
Profiles of cytotoxic T lymphocytes in cutaneous lymphoid hyperplasia of the faceSadanori Furudate, Taku Fujimura, Yumi Kambayashi, et al.
Frontiers in Oncology|December 16, 2021
Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma PatientsKentaro Ohuchi, Yumi Kambayashi, Takanori Hidaka, et al.
Frontiers in Medicine|August 17, 2019
Biomarkers for Predicting Efficacies of Anti-PD1 AntibodiesYumi Kambayashi, Taku Fujimura, Takanori Hidaka, et al.
Pharmaceutics|February 5, 2021
Topical and Systemic Formulation Options for Cutaneous T Cell LymphomasTaku Fujimura, Ryo Amagai, Yumi Kambayashi, et al.
The Journal of Dermatology|October 1, 2024
Segmental lichen aureus: A case report of zosteriform distribution and severe pain with literature reviewJun Yamamoto, Yumi Kambayashi, Shigeru Kuroki, et al.
Case Reports in Dermatology|December 22, 2011
Therapy-resistant, spontaneously remitting generalized neutrophilic eccrine hidradenitis in a healthy patient decreases the expression of dermcidin in affected eccrine glandsYumi Kambayashi, Taku Fujimura, Kenshi Yamasaki, et al.
Case Reports in Dermatology|June 29, 2012
Basal cell carcinoma with spontaneous regression: a case report and immunohistochemical studyTaku Fujimura, Aya Kakizaki, Yumi Kambayashi, et al.
Expert Opinion on Investigational Drugs|December 18, 2018
BRAF kinase inhibitors for treatment of melanoma: developments from early-stage animal studies to Phase II clinical trialsTaku Fujimura, Takanori Hidaka, Yumi Kambayashi, et al.
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Oncoimmunology|December 18, 2012
Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growthTaku Fujimura, Yumi Kambayashi, Setsuya Aiba
Acta Dermato-Venereologica|April 11, 2013
Comparison of immunosuppressive and immunomodulatory cells in keratoacanthoma and cutaneous squamous cell carcinomaYumi Kambayashi, Taku Fujimura, Setsuya Aiba
Case Reports in Dermatology|April 30, 2013
Profiles of cytotoxic T lymphocytes in cutaneous lymphoid hyperplasia of the faceSadanori Furudate, Taku Fujimura, Yumi Kambayashi, et al.
Frontiers in Oncology|December 16, 2021
Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma PatientsKentaro Ohuchi, Yumi Kambayashi, Takanori Hidaka, et al.
Frontiers in Medicine|August 17, 2019
Biomarkers for Predicting Efficacies of Anti-PD1 AntibodiesYumi Kambayashi, Taku Fujimura, Takanori Hidaka, et al.
Pharmaceutics|February 5, 2021
Topical and Systemic Formulation Options for Cutaneous T Cell LymphomasTaku Fujimura, Ryo Amagai, Yumi Kambayashi, et al.
The Journal of Dermatology|October 1, 2024
Segmental lichen aureus: A case report of zosteriform distribution and severe pain with literature reviewJun Yamamoto, Yumi Kambayashi, Shigeru Kuroki, et al.
Case Reports in Dermatology|December 22, 2011
Therapy-resistant, spontaneously remitting generalized neutrophilic eccrine hidradenitis in a healthy patient decreases the expression of dermcidin in affected eccrine glandsYumi Kambayashi, Taku Fujimura, Kenshi Yamasaki, et al.
Case Reports in Dermatology|June 29, 2012
Basal cell carcinoma with spontaneous regression: a case report and immunohistochemical studyTaku Fujimura, Aya Kakizaki, Yumi Kambayashi, et al.
Expert Opinion on Investigational Drugs|December 18, 2018
BRAF kinase inhibitors for treatment of melanoma: developments from early-stage animal studies to Phase II clinical trialsTaku Fujimura, Takanori Hidaka, Yumi Kambayashi, et al.
Pageof 16